đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will evaluate the immunogenicity of a reduced dosing schedule of...
Status
Completed
Location
Chris Hani Baragwanath Academic Hospital
Start Date
2017-01-09
Trial ID
NCT02943902
Treatments Being Tested
Evaluate lot-to-lot consistency, safety and reactogenicity of 3 doses of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11
Trial ID
NCT00307554
Treatments Being Tested
This PMS study aims to collect safety and reactogenicity data of Synflorixâ˘...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01803425
Treatments Being Tested
Pneumococcus is a group of bacteria that can cause pneumonia, meningitis an...
Status
Completed
Location
Pasteur Institute of Ho Chi Minh City
Start Date
2013-09-30
Trial ID
NCT01953510
The study aims to evaluate the safety and immunogenicity of the 10-valent a...
Status
Unknown
Location
Papua New Guinea Institute of Medical Research
Start Date
2011-11
Trial ID
NCT01619462
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of this phase III study is to demonstrate immunologic non-infer...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-28
Trial ID
NCT05721456
Treatments Being Tested
Phase 1/2, Prospective, Single Center, Randomized, ActiveControlled, Double...
Status
Completed
Location
Medical Research Council (MRC) Unit, The Gambia
Start Date
2015-01-12
Trial ID
NCT02308540
Treatments Being Tested
This study is designed to study the immunogenicity and safety of sIPV co-ad...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2023-05-22
Trial ID
NCT05850364
Treatments Being Tested
This study will evaluate the safety, reactogenicity and immunogenicity of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-25
Trial ID
NCT00370396
Treatments Being Tested